why choose us

First received: July 15, 2024

Clinical Trial: Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Helicobacter Pylori Infection

Study Type: INTERVENTIONAL


Official Title: Study on The Efficacy and Safety of Berberine,Amoxicillin and Vonoprazan Containing Triple Therapy in Helicobacter Pylori First-Line Eradication

Brief Summary: The purpose of this study was to evaluate the efficacy and safety of the triple therapy of berberine hydrochloride, vonorasan and amoxicillin for the primary eradication of Helicobacter pylori.It is hypothesized that berberine hydrochloride, amoxicillin and vonoprazan triple therapy is non-inferior to bismuth-containing quadruple therapy.Patients diagnosed with H. pylori infection will be randomly divided into one of the above treatments.At week 6 follow-up visits, a urea breath test?rapid urease test or…

Read more